NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Atour appoints Yingchun Song as director, effective Nov 10, 2025; Cong Lin resigned and will serve as a consultant; no disagreement with the Board noted.Read More
‘Chronically online’ Gen Z turning to these hacks to fight brain rot, reduce social media usageApril 27, 2026